FDA/CDC
FDA/CDC
FDA aims to boost safety of platelets for transfusion
The agency is seeking input on ways to decrease the risk of bacterial contamination in platelets stored for 5 and 7 days after collection.
FDA/CDC
FDA approves sufentanil for adults with acute pain
The opioid is to used for only adult patients in settings that are closely controlled.
News from the FDA/CDC
FDA attacks antibiotic resistance with new strategy
Four-pronged approach addresses product development, stewardship, surveillance, and science.
FDA/CDC
FDA warns kratom vendors about unproven claims
The substance is already outlawed in several countries and banned in some states.
FDA/CDC
Cost led to missed care for 4.5% of Americans in 2017
Steady decline in national rate appears to have halted.
News from the FDA/CDC
FDA issues recommendations to avoid surgical fires
The FDA warned about the safe use of medical devices and products that may increase the risk of surgical fires.
Latest News
FDA alerts clinicians to gastric balloon deaths
Four fatalities followed gastric perforation within a month of balloon placement.
From the Journals
Complication rates rise after decline in uterine fibroid morcellation
The increased rate of open abdominal hysterectomies for the treatment of uterine fibroids is associated with an increased rate of major...
Conference Coverage
VIDEO: Intestinal remodeling contributes to HbA1c drop after Roux-en-Y gastric bypass
Gene expression at 1 month tracked with HbA1c levels out to 1 year post surgery.
Latest News
FDA advisors recommend lofexidine for opioid withdrawal
SILVER SPRING, MD. – A nonopioid agent for symptomatic treatment of opioid withdrawal could be another option to address the opioid epidemic.
FDA/CDC
FDA updates breast implant–associated lymphoma cases, risk
Estimates on the lifetime risk vary widely.